Larry Nelson Thacker, JR.,Michael Viet Thang Vu,Robert Daniel Force,Alexander Nelson Thacker,Aaron Nicholas Adams
申请号：
US15615829
公开号：
US20180344786A1
申请日:
2017.06.06
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A class of medically-effective formulations comprising cannabinoids, and terpenes, using β-myrcene to improve effectiveness. B-myrcene decreases resistance across the blood-brain barrier for both itself and a plurality of other medically-active compounds such as other terpenes, cannabinoids, and flavonoids. Further, β-myrcene has been determined to raise the saturation level of the cannabinoid receptor CB1 for phytocannabinoids such as delta(9)-tetrahydrocannabinol, and to increase cell membrane permeability for itself as well as cannabinoids, terpenes, flavonoids and other naturally occurring cannabis compounds, thereby improving therapeutic benefits of cannbis formulations.
